Showing results (11-20 of 100) with videos related to
Sort By:
Pageof 10
Molecules (Basel, Switzerland)|April 14, 2015
Heparin/Heparan sulfate proteoglycans glycomic interactome in angiogenesis: biological implications and therapeutical usePaola Chiodelli, Antonella Bugatti, Chiara Urbinati, et al.Expert Opinion on Therapeutic Targets|July 1, 2015
The potential of fibroblast growth factor/fibroblast growth factor receptor signaling as a therapeutic target in tumor angiogenesisRoberto Ronca, Arianna Giacomini, Marco Rusnati, et al.Oncotarget|February 15, 2011
Targeting tumor angiogenesis with TSP-1-based compounds: rational design of antiangiogenic mimetics of endogenous inhibitorsGiulia Taraboletti, Marco Rusnati, Laura Ragona, et al.Current Pharmaceutical Design|July 20, 2005
Biotechnological engineering of heparin/heparan sulphate: a novel area of multi-target drug discoveryMarco Rusnati, Pasqua Oreste, Giorgio Zoppetti, et al.Proceedings of the National Academy of Sciences of the United States of America|October 14, 2024
The accomplices: Heparan sulfates and N-glycans foster SARS-CoV-2 spike:ACE2 receptor binding and virus primingGiulia Paiardi, Matheus Ferraz, Marco Rusnati, et al.Trends in Immunology|August 19, 2007
Dendritic cell-endothelial cell cross-talk in angiogenesisSilvano Sozzani, Marco Rusnati, Elena Riboldi, et al.The Journal of Biological Chemistry|April 25, 2012
Sialic acid associated with αvβ3 integrin mediates HIV-1 Tat protein interaction and endothelial cell proangiogenic activationPaola Chiodelli, Chiara Urbinati, Stefania Mitola, et al.Antiviral Research|April 20, 2010
BSA conjugates bearing multiple copies of the basic domain of HIV-1 Tat: Prototype for the development of multitarget inhibitors of extracellular TatAntonella Bugatti, Paola Chiodelli, Joseph Rosenbluh, et al.Pharmaceuticals (Basel, Switzerland)|October 8, 2016
Thrombospondin-1 as a Paradigm for the Development of Antiangiogenic Agents Endowed with Multiple Mechanisms of ActionMarco Rusnati, Chiara Urbinati, Silvia Bonifacio, et al.Future Medicinal Chemistry|December 13, 2018
Sialic acid as a target for the development of novel antiangiogenic strategiesPaola Chiodelli, Chiara Urbinati, Giulia Paiardi, et al.Pageof 10